Crouzon syndrome: Association with absent pulmonary valve syndrome and severe tracheobronchomalacia

Pediatric Pulmonology

Volumn 34, Issue 6, 2002, Pages 478-481

  Beck, Raphael ^a   Sertie, Andrea L ^b   Brik, Riva ^a   Shinawi, Marwan ^a,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Absent pulmonary valve syndrome; Bronchial stents; Crouzon syndrome; Pulmonary artery dilatation; Tracheobronchomalacia

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; AUTOSOMAL DOMINANT INHERITANCE; BRONCHOMALACIA; CASE REPORT; CROUZON SYNDROME; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MOLECULAR GENETICS; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; RECEPTOR GENE; TRACHEOBRONCHOMALACIA; TRACHEOMALACIA; TRACHEOSTOMY;

BRONCHIAL DISEASES; CRANIOFACIAL DYSOSTOSIS; FEMALE; HUMANS; INFANT, NEWBORN; PULMONARY VALVE; RESPIRATION, ARTIFICIAL; SYNDROME; TRACHEAL DISEASES;

EID: 0036891549     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10176     Document Type: Article

References (23)

1. Crouzon O. Dysostose cranio-faciale hereditaire. Bull Mem Soc Med Hop (Paris) 1912;33:545.
2. Jones KL. Smith's Recognizable Patterns of Human Malformation. 5th Ed. Philadelphia: W.B. Saunders Co.; 1997. p 140-141.
3. Lo L-J, Chen Y-R. Airway obstruction in severe syndromic craniosynostosis. Ann Plast Surg 1999;43:258-264.
4. Al-Qattan MM, Phillips JH. Clinical features of Crouzon's syndrome patient with and without a positive family history of Crouzon's syndrome. J Craniofac Surg 1997;8:11-13.
5. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103.
6. Steinberger D, Mulliken JB, Muller U. Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet 1995;96:113-115.
7. Miller S, Dykes DD, Plesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
8. Oldridge M, Wilkie AOM, Slaney SF, Poole MD, Pulleyn LJ, Rutland P, Hockley AD, Wake MJC, Goldin JH, Winter RM, Readon W, Malcolm S. Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet 1995;4:1077-1082.
9. Moore MH. Upper airway obstruction in the syndromal craniosynostosis. Br J Plast Surg 1993;46:355-362.
10. Sculerati N, Gottlieb MD, Zimbler MS, Chibbaro PD, McCarthy JG. Airway management in children with major craniofacial anomalies. Laryngoscope 1998;108:1806-1812.
11. Lauritzen C, Lilja J, Jarlstedt J. Airway obstruction and sleep apnea in children with craniofacial anomalies. Plast Reconstr Surg 1986;77:1-6.
12. Lakier JB, Strangier P, Heymann MA. Tetralogy of Fallot with the absent pulmonary valve syndrome - Natural history and hemodynamic considerations. Circulation 1974;50:167-175.
13. Stellin G, Jonas RA, Goh TH, Brawn WJ, Venables AW, Mee RB. Surgical treatment of absent pulmonary valve syndrome in infants: Relief of bronchial obstruction. Ann Thorac Surg 1983;36:468-475.
14. Subramanian V, Anstead M, Cottrill CM, Kanga J, Gurley J. Tetralogy of Fallot with absent pulmonary valve and bronchial compression: Treatment with endobronchial stents. Pediatr Cardiol 1997;18:237-239.
15. Rabinovitch M, Grady S, David I, Van Praag R, Sauer U, Buhlmeyuer K, Castaneda AR, Reid L. Compression of intrapulmonary bronchi by abnormally branching pulmonary arteries associated with absent pulmonary valves. Am J Cardiol 1982;50:804-813.
16. Siromak J, Brodsky L, Pizzuto M. Airway obstruction in the Crouzon syndrome: Case report and review of the literature. Int J Pediatr Otorhinolaryngol 1995;31:235-246.
17. Jabs EW. Toward understanding the pathogenesis of craniosynostosis through clinical and molecular correlates. Clin Genet [Suppl] 1998;54:6-13.
18. Galvin BD, Hart KC, Myer AN, Webster MK, Donoghue D. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras. Proc Natl Acad Sci USA 1996;93:7894-7899.
19. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao J, Charnas LR, Jackson CE, Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994;8:275-279.
20. Passos-Bueno MR, Sertie AL, Richieri-Costa A, Alonso LG, Zatz M, Alonso N, Brunoni D, Ribeiro S. Description of new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostosis. Am J Med Genet 1998;78:237-241.
21. Rutland P, Pulleyn LJ, Reardon M, Baraitser R, Hayward B, Jones S, Malcolm RM, Winter M, Oldridge SF, Slaney MD, Poole AOM. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 1995;9:173-176.
22. Hughes SE. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 1997;45:1005-1019.
23. Sheikh F, Fandrich RR, Kardami E, Cattini PA. Overexpression of long or short FGFR-1 results in FGFR-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc Res 1999;42:696- 705.